Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks.
Phase of Trial: Phase III
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Ketamine (Primary) ; Venlafaxine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms KETADEP
- 23 Feb 2017 Status changed from active, no longer recruiting to completed.
- 16 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 23 Mar 2016 Planned primary completion date changed from 1 Feb 2015 to 1 Feb 2017 as per ClinicalTrials.gov record.